Combination of a Src Kinase Inhibitor and a BCR-ABL inhibitor for the treatment of proliferative diseases

Details for Australian Patent Application No. 2005304863 (hide)

Owner Bristol-Myers Squibb Company

Inventors Lee, Francis Y.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005304863

PCT Pub. Number WO2006/052810

Priority 60/624,937 04.11.04 US; 60/649,722 03.02.05 US; 60/632,122 01.12.04 US; 60/703,628 29.07.05 US

Filing date 4 November 2005

Wipo publication date 18 May 2006

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052810 Priority application(s): WO2006/052810

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304866-Stable and filterable enveloped virus formulations

2005304859-Insecticidal Polypeptides and Methods of Use Thereof